Prostatic hyperplasia
ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
... With respect to the CYP phenotyping, the positive aspects are that LDT5 is not a substrate of human CYP3A4 and is metabolized by more than one enzyme, properties that decrease the risk of drug-drug interaction (DDI) in ...
9
PREOPERATIVE AND POSTOPERATIVE URODYNAMICS IN PATIENTS OF BENIGN PROSTATIC HYPERPLASIA (TRANSURETHRAL RESECTION OF PROSTATE VS. OPEN PROSTATECTOMY)
... Sujeet Kumar Bhat, Zaheer Abbas, Susheel Kumar Sharma, Monika Koul, Devyani Sawai, Sunil Gupta. Pre- operative and Post-operative Urodynamics in Patients of Benign Prostatic Hyperplasia (Transurethral ...
5
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.
... PSA, a serine protease, is an organ specific molecule produced by the prostatic epithelium. PSA tests introduced in the 1980s provide the opportunity to detect cancer without a positive DRE result. According to ...
14
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
... Prostate cancer is one of the leading causes of mortality among aging males. There is an unmet requirement of clinically useful biomarkers for early detection of prostate cancer to re- duce the liabilities of ...
22
ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
... With respect to the CYP phenotyping, the positive aspects are that LDT5 is not a substrate of human CYP3A4 and is metabolized by more than one enzyme, properties that decrease the risk of drug-drug interaction (DDI) in ...
10
Semen parameters and seminal plasma protein and biochemical profi les of dogs with benign prostatic hyperplasia after botulinum toxin type A intraprostatic injection
... This study aimed to determine the effects of different concentrations of botulinum toxin type A (BT-A) on semen parameters, and seminal plasma biochemical and protein profi les of dogs with benign prostatic ...
6
Impact of pharmacologic therapy for benign prostatic hyperplasia on prostate volume and free testosterone and consequently on urinary parameters and sexual desire in men
... Benign prostatic hyperplasia (BPH) is the fourth most common disease in elderly men. It causes difficulties in urina- tion and sexual function disorders. The occurrence and deve- lopment of BPH are ...
7
Benign prostatic hyperplasia and prostate-specific antigen
... Benign prostatic hyperplasia is common among mem- bers of Western civilization; however, there is an increasing incidence of BPH in Asian countries, with traditionally low prevalence of BPH 13 ...
7
Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia : a randomized, placebocontrolled clinical trial
... Benign prostatic hyperplasia (BPH) is the most common disease of the urinary tract in elderly patients ...and prostatic enlargement presumably caused by bladder outlet obstruction (BOO) ...with ...
5
Nonspecific genitourinary pain improves after prostatectomy using holmium laser enucleation of prostate in patients with benign prostatic hyperplasia: a prospective study.
... Among the 100 patients, 56 (56.0%) had LUTS alone, and the remaining 44 (44.0%) patients had LUTS and GUDP (Figure 1). The location of pain or discomfort included the suprapubic (43.2%), perineal/penile (34.1%), back ...
6
Benign prostatic hyperplasia: laser prostatectomy (PVP)
... and prostatic volume < 100 mL (N: 200), com- parison between PVP (HPS with 80-W KTP laser) (N: 100) and transurethral resection of the prostate (conventional TURP) (N: 100) made it possible to assess the ...
12
Nocturia and benign prostatic hyperplasia
... Background/Aim. Nocturia often occures in patients with benign prostata hyperplasia (BPH). The aim of the study was to investigate the frequency of nocturia in patients with BPH. Nocturia and other factors ...
4
Einstein (São Paulo) vol.13 número3 eins S1679
... Giant prostatic hyperplasia is a rare condition characterized by very high volume benign prostatic enlargement ...giant prostatic hyperplasia in an elderly man who had a 720g prostate ...
3
Int. braz j urol. vol.40 número1
... benign prostatic hyperplasia, glomerulonephritis as cause of chronic renal failure (CRF), smoking habits, lower cre- atinine levels (ULRA), use of calcium channel blocker (MLRA), aging, lower education ...
12
Serum and urinary measurements of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in dogs
... ARMBRUSTER, D.A. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin. Chem., v.39, p.181-195, 1993. AUMÜLLER, G.; VEDDER, H.; ENDERLE- SCHMITT, U. et al. Cytochemistry and ...
5
Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil
... The presence of human papillomavirus (HPV) was evaluated in 65 samples of prostate tumours and six samples of prostates with benign prostatic hyperplasia from individuals from Northern Brazil. We used a ...
3
Int. braz j urol. vol.36 número6
... intravesical prostatic protrusion, and the as- sociation of each test to diagnose bladder prostatic obstruction in patients with lower urinary tract ...intravesical prostatic protrusion, detrusor ...
4
Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.
... benign prostatic hyperplasia proved by prostate biopsy were scanned on a ...benign prostatic hyperplasia, hemorrhage was detected only in 1 patient in prostate by ...had prostatic ...
7
Int. braz j urol. vol.40 número2
... Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D: Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol[r] ...
7